

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.03087827 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.96531050 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.93258469 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.46454069 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.31065879 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.30555977 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.30126604 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.28343050 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.21891131 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.17294370 |
| 11 | regulation of synapse structural plasticity (GO:0051823) | 4.11756930 |
| 12 | vocalization behavior (GO:0071625) | 4.00828387 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96472217 |
| 14 | glutamate secretion (GO:0014047) | 3.96279278 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92790799 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91675866 |
| 17 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.80678253 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.76199428 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.68072346 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.63919959 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.61473026 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.57790118 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56637650 |
| 24 | exploration behavior (GO:0035640) | 3.48954447 |
| 25 | protein localization to synapse (GO:0035418) | 3.48770152 |
| 26 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48749306 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46328210 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39716348 |
| 29 | prepulse inhibition (GO:0060134) | 3.38235354 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37204796 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37204796 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 3.37204796 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37204796 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.37204796 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37204796 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.36473376 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.34880640 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33992740 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.33399456 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.32090664 |
| 41 | mannose metabolic process (GO:0006013) | 3.31192893 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.28636630 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 3.27745812 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.27564243 |
| 45 | glycine transport (GO:0015816) | 3.25711687 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 3.23782922 |
| 47 | synaptic vesicle endocytosis (GO:0048488) | 3.23475826 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.23243566 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21901827 |
| 50 | long-term memory (GO:0007616) | 3.21185879 |
| 51 | neuron-neuron synaptic transmission (GO:0007270) | 3.18722665 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.15078829 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.14638957 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10587077 |
| 55 | membrane depolarization during action potential (GO:0086010) | 3.09090917 |
| 56 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.07323979 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07229741 |
| 58 | proline transport (GO:0015824) | 3.06474491 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.04852515 |
| 60 | neuromuscular process controlling balance (GO:0050885) | 3.03449473 |
| 61 | neuron cell-cell adhesion (GO:0007158) | 3.02517742 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00715410 |
| 63 | vesicle transport along microtubule (GO:0047496) | 3.00590563 |
| 64 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00303419 |
| 65 | sodium ion export (GO:0071436) | 2.98840786 |
| 66 | long-term synaptic potentiation (GO:0060291) | 2.96839458 |
| 67 | activation of protein kinase A activity (GO:0034199) | 2.95642762 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 2.94187535 |
| 69 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.93277554 |
| 70 | germinal center formation (GO:0002467) | 2.93127926 |
| 71 | positive regulation of membrane potential (GO:0045838) | 2.91983783 |
| 72 | negative regulation of cell killing (GO:0031342) | 2.90583428 |
| 73 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.90583428 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.90374104 |
| 75 | dendrite morphogenesis (GO:0048813) | 2.90372075 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.90238909 |
| 77 | signal complex assembly (GO:0007172) | 2.88091126 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87799814 |
| 79 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.87262510 |
| 80 | positive thymic T cell selection (GO:0045059) | 2.85786688 |
| 81 | leukocyte aggregation (GO:0070486) | 2.83650381 |
| 82 | auditory behavior (GO:0031223) | 2.83091849 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 2.83027361 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.82906437 |
| 85 | neurotransmitter transport (GO:0006836) | 2.81734487 |
| 86 | membrane depolarization (GO:0051899) | 2.81632693 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 2.80569282 |
| 88 | response to auditory stimulus (GO:0010996) | 2.79238557 |
| 89 | regulation of Rap GTPase activity (GO:0032317) | 2.78481213 |
| 90 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.76931085 |
| 91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76733142 |
| 92 | positive regulation of Rap GTPase activity (GO:0032854) | 2.75991440 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74344670 |
| 94 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.73918493 |
| 95 | nerve growth factor signaling pathway (GO:0038180) | 2.73649661 |
| 96 | transmission of nerve impulse (GO:0019226) | 2.73157425 |
| 97 | positive regulation of neurotransmitter transport (GO:0051590) | 2.73014355 |
| 98 | negative thymic T cell selection (GO:0045060) | 2.72534039 |
| 99 | dendritic spine morphogenesis (GO:0060997) | 2.72168366 |
| 100 | striatum development (GO:0021756) | 2.71678583 |
| 101 | B cell receptor signaling pathway (GO:0050853) | 2.69033207 |
| 102 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.68518441 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.68424074 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 2.68242343 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.66875838 |
| 106 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66179924 |
| 107 | regulation of vesicle fusion (GO:0031338) | 2.65588047 |
| 108 | dopamine receptor signaling pathway (GO:0007212) | 2.64408651 |
| 109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64299075 |
| 110 | detection of bacterium (GO:0016045) | 2.64130915 |
| 111 | adult walking behavior (GO:0007628) | 2.63723630 |
| 112 | regulation of ARF GTPase activity (GO:0032312) | 2.63699592 |
| 113 | clathrin coat assembly (GO:0048268) | 2.63300925 |
| 114 | detection of other organism (GO:0098543) | 2.63034329 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.62765339 |
| 116 | activated T cell proliferation (GO:0050798) | 2.62323437 |
| 117 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.61971872 |
| 118 | adenosine receptor signaling pathway (GO:0001973) | 2.61178023 |
| 119 | regulation of regulated secretory pathway (GO:1903305) | 2.60880497 |
| 120 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.60392518 |
| 121 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60022550 |
| 122 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.59847247 |
| 123 | positive regulation of synaptic transmission (GO:0050806) | 2.59816232 |
| 124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.59611057 |
| 125 | neuronal ion channel clustering (GO:0045161) | 2.57699248 |
| 126 | L-amino acid import (GO:0043092) | 2.56852529 |
| 127 | cellular extravasation (GO:0045123) | 2.56407284 |
| 128 | regulation of beta-amyloid formation (GO:1902003) | 2.56189918 |
| 129 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.55745694 |
| 130 | response to interleukin-15 (GO:0070672) | 2.55084882 |
| 131 | organelle transport along microtubule (GO:0072384) | 2.53908341 |
| 132 | potassium ion import (GO:0010107) | 2.53872800 |
| 133 | membrane hyperpolarization (GO:0060081) | 2.53712594 |
| 134 | response to amphetamine (GO:0001975) | 2.53405919 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53192376 |
| 136 | negative regulation of interleukin-12 production (GO:0032695) | 2.52795027 |
| 137 | thymic T cell selection (GO:0045061) | 2.52729301 |
| 138 | mating behavior (GO:0007617) | 2.52578699 |
| 139 | response to peptidoglycan (GO:0032494) | 2.51955650 |
| 140 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51801795 |
| 141 | cell migration in hindbrain (GO:0021535) | 2.51125318 |
| 142 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.50877309 |
| 143 | T cell selection (GO:0045058) | 2.50366740 |
| 144 | regulation of mast cell degranulation (GO:0043304) | 2.49767800 |
| 145 | T cell migration (GO:0072678) | 2.49430847 |
| 146 | negative T cell selection (GO:0043383) | 2.48971629 |
| 147 | positive T cell selection (GO:0043368) | 2.48913099 |
| 148 | response to type I interferon (GO:0034340) | 2.48910772 |
| 149 | regulation of leukocyte degranulation (GO:0043300) | 2.48198072 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.45719330 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.45719330 |
| 152 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43809140 |
| 153 | microglial cell activation (GO:0001774) | 2.41891079 |
| 154 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36661657 |
| 155 | positive regulation of mast cell activation (GO:0033005) | 2.36509642 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35097387 |
| 157 | response to host immune response (GO:0052572) | 2.35097387 |
| 158 | establishment of mitochondrion localization (GO:0051654) | 2.32537030 |
| 159 | NIK/NF-kappaB signaling (GO:0038061) | 2.32318871 |
| 160 | positive regulation of synapse maturation (GO:0090129) | 2.32258515 |
| 161 | cerebellar granule cell differentiation (GO:0021707) | 2.31955742 |
| 162 | tolerance induction (GO:0002507) | 2.31556729 |
| 163 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.30716803 |
| 164 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.30055622 |
| 165 | neutrophil activation involved in immune response (GO:0002283) | 2.29612859 |
| 166 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.29427335 |
| 167 | positive regulation of mast cell degranulation (GO:0043306) | 2.29427335 |
| 168 | positive regulation of type 2 immune response (GO:0002830) | 2.28747293 |
| 169 | negative regulation of type 2 immune response (GO:0002829) | 2.28092841 |
| 170 | macrophage activation (GO:0042116) | 2.26283207 |
| 171 | positive regulation of B cell differentiation (GO:0045579) | 2.25398730 |
| 172 | myeloid cell activation involved in immune response (GO:0002275) | 2.24752152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.35719908 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.94001494 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80159739 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71522056 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65590750 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59270624 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.52665363 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50233462 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.49727479 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48568508 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.40280675 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.29973618 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.28692999 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28374504 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25682351 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.24273284 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23146894 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23146894 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.21407785 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16752761 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09967769 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09566835 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09526119 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08982324 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03650050 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98314610 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.92972378 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91273238 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82890830 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82147149 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78180281 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77333455 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70409239 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.67683061 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67599745 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63053645 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62216953 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61792040 |
| 39 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.61240361 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57993101 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57604433 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55448792 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54455550 |
| 44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50659267 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49095608 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48898559 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48130310 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46192411 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45203248 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44937102 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44933722 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.42870738 |
| 53 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41735894 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40503046 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.39373600 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38948963 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38436203 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36034298 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34504935 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34093805 |
| 61 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33335491 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30777162 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29423425 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29198421 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28875934 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27167405 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25887495 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25686540 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25261119 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22023173 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19649958 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19415622 |
| 73 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.17921911 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17221007 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15835132 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15775564 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15652335 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14723449 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14077702 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13742818 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13430086 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12773245 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12603073 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12012777 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 1.11806662 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11754528 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11549945 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09447401 |
| 89 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09349462 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08109549 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07638115 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06242804 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05628609 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04982884 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04826705 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04785853 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04242868 |
| 98 | * GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03787753 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03405108 |
| 100 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03383038 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00828932 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00067207 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00055308 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99702581 |
| 105 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99286806 |
| 106 | MYB_26560356_Chip-Seq_TH2_Human | 0.99224750 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98639529 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98369804 |
| 109 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98190730 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97641528 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97372105 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96397069 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95508537 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94716470 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94640742 |
| 116 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94621121 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94488884 |
| 118 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94197558 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93854143 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93751265 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92560821 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92272058 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92146707 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89514082 |
| 125 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88880021 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88777439 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88343931 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88076886 |
| 129 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88072419 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87366866 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87069808 |
| 132 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86726422 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85842293 |
| 134 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85608054 |
| 135 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84446641 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83717128 |
| 137 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.82988941 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82841319 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82150788 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81809498 |
| 141 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81466549 |
| 142 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81356142 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80519574 |
| 144 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80515389 |
| 145 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79991857 |
| 146 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79395291 |
| 147 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79100273 |
| 148 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78334766 |
| 149 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.78053895 |
| 150 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75945482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.02741254 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.74229069 |
| 3 | MP0003880_abnormal_central_pattern | 3.66123742 |
| 4 | MP0002822_catalepsy | 3.55249293 |
| 5 | MP0003436_decreased_susceptibility_to | 3.26608108 |
| 6 | MP0004270_analgesia | 3.12410318 |
| 7 | MP0009745_abnormal_behavioral_response | 3.06702952 |
| 8 | MP0002064_seizures | 3.04801693 |
| 9 | MP0009046_muscle_twitch | 3.03678779 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.93339626 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.69541815 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.59701176 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.49250705 |
| 14 | MP0003724_increased_susceptibility_to | 2.43809279 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.35496947 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.35458766 |
| 17 | MP0002272_abnormal_nervous_system | 2.35194666 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.29880244 |
| 19 | MP0001486_abnormal_startle_reflex | 2.24021596 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.21392478 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.19603749 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.19563853 |
| 23 | MP0005671_abnormal_response_to | 2.17356392 |
| 24 | MP0002736_abnormal_nociception_after | 2.14934267 |
| 25 | MP0008569_lethality_at_weaning | 2.09035952 |
| 26 | MP0009278_abnormal_bone_marrow | 2.01087426 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.95530885 |
| 28 | MP0001970_abnormal_pain_threshold | 1.92212486 |
| 29 | MP0000685_abnormal_immune_system | 1.91217963 |
| 30 | MP0002419_abnormal_innate_immunity | 1.88519045 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.88279399 |
| 32 | MP0005025_abnormal_response_to | 1.86162770 |
| 33 | MP0003329_amyloid_beta_deposits | 1.83376055 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.81101402 |
| 35 | MP0002723_abnormal_immune_serum | 1.78781078 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.78486371 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.75717812 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.74053167 |
| 39 | MP0003303_peritoneal_inflammation | 1.73043489 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.67980566 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.66788622 |
| 42 | MP0001819_abnormal_immune_cell | 1.64587388 |
| 43 | MP0004858_abnormal_nervous_system | 1.64256231 |
| 44 | MP0004924_abnormal_behavior | 1.63252269 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.63252269 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.62332178 |
| 47 | MP0003787_abnormal_imprinting | 1.61108409 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.57658253 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.57246914 |
| 50 | MP0004510_myositis | 1.56337718 |
| 51 | MP0004947_skin_inflammation | 1.46801985 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.46331435 |
| 53 | MP0003633_abnormal_nervous_system | 1.45499418 |
| 54 | MP0002184_abnormal_innervation | 1.44714585 |
| 55 | MP0009785_altered_susceptibility_to | 1.42858723 |
| 56 | MP0000955_abnormal_spinal_cord | 1.40996305 |
| 57 | MP0000604_amyloidosis | 1.39647311 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.38063335 |
| 59 | MP0000778_abnormal_nervous_system | 1.36828212 |
| 60 | MP0006082_CNS_inflammation | 1.35100596 |
| 61 | MP0008260_abnormal_autophagy | 1.34441469 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.32251972 |
| 63 | MP0003879_abnormal_hair_cell | 1.29834808 |
| 64 | MP0000716_abnormal_immune_system | 1.29830744 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.26488704 |
| 66 | MP0002398_abnormal_bone_marrow | 1.25698818 |
| 67 | MP0003075_altered_response_to | 1.23611257 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.21227980 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.20574473 |
| 70 | MP0008874_decreased_physiological_sensi | 1.16285503 |
| 71 | MP0003631_nervous_system_phenotype | 1.15801866 |
| 72 | MP0003866_abnormal_defecation | 1.15267320 |
| 73 | MP0003690_abnormal_glial_cell | 1.14676209 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.14414698 |
| 75 | MP0004885_abnormal_endolymph | 1.13799534 |
| 76 | MP0000920_abnormal_myelination | 1.12751019 |
| 77 | MP0001984_abnormal_olfaction | 1.12206888 |
| 78 | MP0001529_abnormal_vocalization | 1.10889782 |
| 79 | MP0004142_abnormal_muscle_tone | 1.08596792 |
| 80 | MP0000751_myopathy | 1.08165223 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.07468535 |
| 82 | MP0002229_neurodegeneration | 1.07255403 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.06849956 |
| 84 | MP0003634_abnormal_glial_cell | 1.06557154 |
| 85 | MP0002405_respiratory_system_inflammati | 1.06529940 |
| 86 | MP0005535_abnormal_body_temperature | 1.03177456 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.03024434 |
| 88 | MP0001348_abnormal_lacrimal_gland | 1.02827935 |
| 89 | MP0010155_abnormal_intestine_physiology | 1.00562000 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.97391525 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.93584961 |
| 92 | MP0002429_abnormal_blood_cell | 0.92852404 |
| 93 | MP0010386_abnormal_urinary_bladder | 0.91900087 |
| 94 | MP0002722_abnormal_immune_system | 0.91666521 |
| 95 | MP0001905_abnormal_dopamine_level | 0.91167341 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.90514378 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.88762406 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.88762406 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.88756911 |
| 100 | MP0004381_abnormal_hair_follicle | 0.88688466 |
| 101 | MP0000689_abnormal_spleen_morphology | 0.88328831 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.88046217 |
| 103 | MP0004742_abnormal_vestibular_system | 0.86841865 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.83416524 |
| 105 | MP0002090_abnormal_vision | 0.83035646 |
| 106 | MP0001873_stomach_inflammation | 0.82834241 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.82741131 |
| 108 | MP0008872_abnormal_physiological_respon | 0.81870819 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.81694506 |
| 110 | MP0004085_abnormal_heartbeat | 0.81533842 |
| 111 | MP0005409_darkened_coat_color | 0.80864673 |
| 112 | MP0002152_abnormal_brain_morphology | 0.79472036 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.78708891 |
| 114 | MP0003632_abnormal_nervous_system | 0.78463438 |
| 115 | MP0005551_abnormal_eye_electrophysiolog | 0.73246760 |
| 116 | MP0001790_abnormal_immune_system | 0.72097826 |
| 117 | MP0005387_immune_system_phenotype | 0.72097826 |
| 118 | MP0004130_abnormal_muscle_cell | 0.70859272 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.70541322 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.70495816 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.65934372 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.64148455 |
| 123 | MP0003122_maternal_imprinting | 0.63546687 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.61945532 |
| 125 | MP0005166_decreased_susceptibility_to | 0.61566436 |
| 126 | MP0005448_abnormal_energy_balance | 0.59415563 |
| 127 | MP0001188_hyperpigmentation | 0.58107880 |
| 128 | MP0005310_abnormal_salivary_gland | 0.57820188 |
| 129 | MP0003283_abnormal_digestive_organ | 0.57576240 |
| 130 | MP0003045_fibrosis | 0.56760893 |
| 131 | MP0001800_abnormal_humoral_immune | 0.55949674 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.55586456 |
| 133 | MP0001835_abnormal_antigen_presentation | 0.53654729 |
| 134 | MP0004043_abnormal_pH_regulation | 0.53587534 |
| 135 | MP0001664_abnormal_digestion | 0.52663434 |
| 136 | MP0005000_abnormal_immune_tolerance | 0.52125377 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.51981294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.75040429 |
| 2 | Focal motor seizures (HP:0011153) | 5.32887962 |
| 3 | Focal seizures (HP:0007359) | 4.82633276 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 4.19234246 |
| 5 | Visual hallucinations (HP:0002367) | 4.18373253 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.90028248 |
| 7 | Atonic seizures (HP:0010819) | 3.86110448 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.82883100 |
| 9 | Febrile seizures (HP:0002373) | 3.80064252 |
| 10 | Action tremor (HP:0002345) | 3.76393839 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.67657340 |
| 12 | Obstructive sleep apnea (HP:0002870) | 3.41327415 |
| 13 | Ankle clonus (HP:0011448) | 3.34097069 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.33598458 |
| 15 | Myositis (HP:0100614) | 3.29675563 |
| 16 | Depression (HP:0000716) | 3.28853601 |
| 17 | Absence seizures (HP:0002121) | 3.27336326 |
| 18 | Truncal ataxia (HP:0002078) | 3.17830699 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.17278383 |
| 20 | Dialeptic seizures (HP:0011146) | 3.15870138 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.08141020 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04895964 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.02927246 |
| 24 | Optic neuritis (HP:0100653) | 3.02927246 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.01576116 |
| 26 | Orchitis (HP:0100796) | 3.00933098 |
| 27 | Progressive inability to walk (HP:0002505) | 3.00320539 |
| 28 | Anxiety (HP:0000739) | 2.96464778 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.92556479 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.90717106 |
| 31 | Dysmetria (HP:0001310) | 2.90316710 |
| 32 | Postural instability (HP:0002172) | 2.86726752 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.86200706 |
| 34 | Spastic gait (HP:0002064) | 2.84518949 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.83995003 |
| 36 | Urinary urgency (HP:0000012) | 2.81490123 |
| 37 | Impaired social interactions (HP:0000735) | 2.80340696 |
| 38 | Abnormal social behavior (HP:0012433) | 2.80340696 |
| 39 | Broad-based gait (HP:0002136) | 2.76517017 |
| 40 | Genetic anticipation (HP:0003743) | 2.73522927 |
| 41 | Poor eye contact (HP:0000817) | 2.70157343 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.70013629 |
| 43 | Papilledema (HP:0001085) | 2.68729614 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65777901 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.58755252 |
| 46 | Meningitis (HP:0001287) | 2.55301032 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.55020843 |
| 48 | Diplopia (HP:0000651) | 2.55020843 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.54819981 |
| 50 | Scanning speech (HP:0002168) | 2.53885875 |
| 51 | Impaired smooth pursuit (HP:0007772) | 2.45988390 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45228401 |
| 53 | Hemiplegia (HP:0002301) | 2.43194622 |
| 54 | Abnormality of the lower motor neuron (HP:0002366) | 2.42778699 |
| 55 | Obstructive lung disease (HP:0006536) | 2.42458108 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42458108 |
| 57 | Resting tremor (HP:0002322) | 2.40747933 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.36837120 |
| 59 | Dysmetric saccades (HP:0000641) | 2.36324660 |
| 60 | Torticollis (HP:0000473) | 2.36210088 |
| 61 | Increased IgE level (HP:0003212) | 2.35735177 |
| 62 | Bradykinesia (HP:0002067) | 2.34951149 |
| 63 | Episodic fever (HP:0001954) | 2.34329307 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.31743177 |
| 65 | Apathy (HP:0000741) | 2.31095352 |
| 66 | Vasculitis (HP:0002633) | 2.30773261 |
| 67 | Stereotypic behavior (HP:0000733) | 2.30673622 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.27712714 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23329660 |
| 70 | Cellulitis (HP:0100658) | 2.22604486 |
| 71 | Mutism (HP:0002300) | 2.22408226 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21982183 |
| 73 | Excessive salivation (HP:0003781) | 2.21188203 |
| 74 | Drooling (HP:0002307) | 2.21188203 |
| 75 | Psychosis (HP:0000709) | 2.20142531 |
| 76 | Diminished motivation (HP:0000745) | 2.19624272 |
| 77 | Hemiparesis (HP:0001269) | 2.19333200 |
| 78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17850669 |
| 79 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17850669 |
| 80 | Recurrent skin infections (HP:0001581) | 2.17746711 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.17489915 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.16654266 |
| 83 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.16301646 |
| 84 | Abnormal hair whorl (HP:0010721) | 2.16128037 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.15230585 |
| 86 | Absent speech (HP:0001344) | 2.15093908 |
| 87 | Lower limb amyotrophy (HP:0007210) | 2.14651964 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14522253 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.14500868 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14436337 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14436337 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14436337 |
| 93 | Abnormality of saccadic eye movements (HP:0000570) | 2.14190299 |
| 94 | Abnormality of the corticospinal tract (HP:0002492) | 2.13661587 |
| 95 | Slow saccadic eye movements (HP:0000514) | 2.12371125 |
| 96 | Macroorchidism (HP:0000053) | 2.12044654 |
| 97 | Hyperventilation (HP:0002883) | 2.11668695 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.10667590 |
| 99 | Focal dystonia (HP:0004373) | 2.10449883 |
| 100 | Abnormality of the fingertips (HP:0001211) | 2.09477280 |
| 101 | Global brain atrophy (HP:0002283) | 2.09399708 |
| 102 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09243677 |
| 103 | Amyloidosis (HP:0011034) | 2.08719931 |
| 104 | Intention tremor (HP:0002080) | 2.08329346 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.06390445 |
| 106 | Gingivitis (HP:0000230) | 2.05790873 |
| 107 | Spinal canal stenosis (HP:0003416) | 2.05486960 |
| 108 | Pointed chin (HP:0000307) | 2.05431833 |
| 109 | Recurrent sinusitis (HP:0011108) | 2.04571748 |
| 110 | Memory impairment (HP:0002354) | 2.03631488 |
| 111 | Encephalitis (HP:0002383) | 2.03263945 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02881883 |
| 113 | Amblyopia (HP:0000646) | 2.02480139 |
| 114 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02182867 |
| 115 | Agitation (HP:0000713) | 2.01056377 |
| 116 | Status epilepticus (HP:0002133) | 2.00047054 |
| 117 | Epileptiform EEG discharges (HP:0011182) | 1.99352123 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 1.98292544 |
| 119 | Loss of speech (HP:0002371) | 1.98248997 |
| 120 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97626709 |
| 121 | Insomnia (HP:0100785) | 1.97503814 |
| 122 | Impaired vibratory sensation (HP:0002495) | 1.96922063 |
| 123 | Onion bulb formation (HP:0003383) | 1.96844656 |
| 124 | Agammaglobulinemia (HP:0004432) | 1.96472230 |
| 125 | Rigidity (HP:0002063) | 1.96421980 |
| 126 | Hemoptysis (HP:0002105) | 1.95904344 |
| 127 | Insidious onset (HP:0003587) | 1.95560925 |
| 128 | Termporal pattern (HP:0011008) | 1.95560925 |
| 129 | Colitis (HP:0002583) | 1.95470286 |
| 130 | Inability to walk (HP:0002540) | 1.95424032 |
| 131 | Iris hypopigmentation (HP:0007730) | 1.94891628 |
| 132 | Stomatitis (HP:0010280) | 1.92962506 |
| 133 | Pheochromocytoma (HP:0002666) | 1.92751257 |
| 134 | Chest pain (HP:0100749) | 1.92054742 |
| 135 | Spontaneous hematomas (HP:0007420) | 1.90704277 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.89891845 |
| 137 | Blue irides (HP:0000635) | 1.89887012 |
| 138 | Panhypogammaglobulinemia (HP:0003139) | 1.88585261 |
| 139 | Limb dystonia (HP:0002451) | 1.88194981 |
| 140 | Craniofacial dystonia (HP:0012179) | 1.88166134 |
| 141 | Hypsarrhythmia (HP:0002521) | 1.88016527 |
| 142 | Postural tremor (HP:0002174) | 1.87886327 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 1.85249663 |
| 144 | Failure to thrive in infancy (HP:0001531) | 1.84764886 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.84054428 |
| 146 | Hyperacusis (HP:0010780) | 1.83919823 |
| 147 | Annular pancreas (HP:0001734) | 1.83770547 |
| 148 | Vertebral arch anomaly (HP:0008438) | 1.83220269 |
| 149 | Clonus (HP:0002169) | 1.82308903 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.81118782 |
| 151 | Pulmonary embolism (HP:0002204) | 1.80878781 |
| 152 | Generalized hypotonia (HP:0001290) | 1.80624217 |
| 153 | Recurrent viral infections (HP:0004429) | 1.80280361 |
| 154 | Megalencephaly (HP:0001355) | 1.79869531 |
| 155 | Rapidly progressive (HP:0003678) | 1.79196013 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.74157050 |
| 157 | Chronic otitis media (HP:0000389) | 1.72967812 |
| 158 | Personality changes (HP:0000751) | 1.72760524 |
| 159 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72175489 |
| 160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72175489 |
| 161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72175489 |
| 162 | Disinhibition (HP:0000734) | 1.71512071 |
| 163 | Pustule (HP:0200039) | 1.71416863 |
| 164 | Sleep apnea (HP:0010535) | 1.71270296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.70820901 |
| 2 | EPHA4 | 3.64350117 |
| 3 | MAP3K9 | 3.00126574 |
| 4 | DAPK2 | 2.85613602 |
| 5 | RIPK4 | 2.81362248 |
| 6 | SIK2 | 2.51363812 |
| 7 | MAP3K4 | 2.43679043 |
| 8 | TRIB3 | 2.23537058 |
| 9 | MARK1 | 2.16388832 |
| 10 | MAP3K13 | 2.10650661 |
| 11 | FES | 2.07314057 |
| 12 | MINK1 | 2.01611306 |
| 13 | PAK6 | 2.00811598 |
| 14 | MAP2K7 | 1.90824478 |
| 15 | CDK12 | 1.89338247 |
| 16 | CAMKK1 | 1.71262997 |
| 17 | SIK3 | 1.69791359 |
| 18 | NTRK2 | 1.66676317 |
| 19 | NTRK1 | 1.61327199 |
| 20 | KSR2 | 1.60193738 |
| 21 | CDK5 | 1.53780015 |
| 22 | DAPK1 | 1.46564402 |
| 23 | PRKD3 | 1.45556495 |
| 24 | PRKCH | 1.43923725 |
| 25 | PRPF4B | 1.43373891 |
| 26 | TYK2 | 1.40428930 |
| 27 | MAP2K4 | 1.38647965 |
| 28 | BLK | 1.35062026 |
| 29 | UHMK1 | 1.34023059 |
| 30 | SGK3 | 1.33197128 |
| 31 | SGK494 | 1.28353307 |
| 32 | SGK223 | 1.28353307 |
| 33 | MAP4K1 | 1.24174672 |
| 34 | CAMK1G | 1.23410314 |
| 35 | SGK2 | 1.20255499 |
| 36 | IRAK4 | 1.19925639 |
| 37 | TBK1 | 1.19304511 |
| 38 | CAMKK2 | 1.18835209 |
| 39 | TNK2 | 1.17322130 |
| 40 | ICK | 1.16469066 |
| 41 | GRK5 | 1.14872989 |
| 42 | MAP3K11 | 1.11514294 |
| 43 | CSK | 1.08043854 |
| 44 | FGFR4 | 1.07998838 |
| 45 | MARK2 | 1.07268083 |
| 46 | ZAP70 | 1.05629282 |
| 47 | TAOK1 | 1.02884391 |
| 48 | MAP3K2 | 0.98118716 |
| 49 | SIK1 | 0.97354334 |
| 50 | MAP3K12 | 0.96398120 |
| 51 | BTK | 0.96264424 |
| 52 | TYRO3 | 0.95846124 |
| 53 | TNIK | 0.95392318 |
| 54 | MAPK13 | 0.91700358 |
| 55 | JAK1 | 0.91593583 |
| 56 | KSR1 | 0.91394361 |
| 57 | JAK3 | 0.90833535 |
| 58 | TXK | 0.90339319 |
| 59 | STK38 | 0.88400190 |
| 60 | MAPK12 | 0.86017229 |
| 61 | CASK | 0.85937303 |
| 62 | SYK | 0.85164976 |
| 63 | ALK | 0.84202887 |
| 64 | RET | 0.83742988 |
| 65 | PRKCG | 0.82585994 |
| 66 | CAMK1 | 0.82463275 |
| 67 | MAP3K7 | 0.80056747 |
| 68 | WNK1 | 0.79909126 |
| 69 | MATK | 0.79564325 |
| 70 | SGK1 | 0.79187434 |
| 71 | CSF1R | 0.78785374 |
| 72 | PDK1 | 0.77990958 |
| 73 | PDPK1 | 0.74539478 |
| 74 | FGR | 0.74388289 |
| 75 | MAP3K1 | 0.74350307 |
| 76 | HCK | 0.74223446 |
| 77 | EPHB1 | 0.73334607 |
| 78 | LCK | 0.72430105 |
| 79 | PHKG1 | 0.70416608 |
| 80 | PHKG2 | 0.70416608 |
| 81 | FGFR3 | 0.69470737 |
| 82 | CDC42BPA | 0.68929783 |
| 83 | PTK2B | 0.68725626 |
| 84 | NEK6 | 0.68024507 |
| 85 | CAMK4 | 0.68020840 |
| 86 | FYN | 0.67066942 |
| 87 | DYRK1B | 0.66832177 |
| 88 | MAP2K6 | 0.64584993 |
| 89 | LYN | 0.64165128 |
| 90 | STK11 | 0.63829347 |
| 91 | MAP2K3 | 0.63299435 |
| 92 | INSRR | 0.62855354 |
| 93 | TAOK2 | 0.61415869 |
| 94 | HIPK2 | 0.60830880 |
| 95 | CDK18 | 0.59360058 |
| 96 | TAOK3 | 0.58750041 |
| 97 | CAMK1D | 0.58702436 |
| 98 | MAP2K2 | 0.55951098 |
| 99 | CDK15 | 0.55873454 |
| 100 | PLK2 | 0.55735184 |
| 101 | CDK19 | 0.55581123 |
| 102 | RIPK1 | 0.55486762 |
| 103 | ARAF | 0.54138436 |
| 104 | RPS6KA2 | 0.53812368 |
| 105 | LMTK2 | 0.53300698 |
| 106 | RPS6KA3 | 0.53219017 |
| 107 | MAPK10 | 0.53177545 |
| 108 | ERN1 | 0.52739070 |
| 109 | PKN1 | 0.52381861 |
| 110 | PRKD2 | 0.52271021 |
| 111 | DYRK1A | 0.52117838 |
| 112 | CAMK2A | 0.51857397 |
| 113 | EPHA3 | 0.51780371 |
| 114 | EEF2K | 0.50599926 |
| 115 | PRKCZ | 0.50208837 |
| 116 | IKBKB | 0.50082538 |
| 117 | ITK | 0.49838939 |
| 118 | CDK11A | 0.49769914 |
| 119 | PRKD1 | 0.49505006 |
| 120 | SMG1 | 0.49222647 |
| 121 | PRKCQ | 0.48025336 |
| 122 | CDK14 | 0.47819158 |
| 123 | CAMK2B | 0.46891632 |
| 124 | DAPK3 | 0.46527848 |
| 125 | GRK6 | 0.46148013 |
| 126 | IRAK3 | 0.45839234 |
| 127 | JAK2 | 0.45489136 |
| 128 | CSNK1G2 | 0.44347795 |
| 129 | IKBKE | 0.44214285 |
| 130 | BMPR2 | 0.44132874 |
| 131 | PINK1 | 0.43183185 |
| 132 | MAPK7 | 0.43017413 |
| 133 | GRK7 | 0.42368252 |
| 134 | MAP3K14 | 0.41182840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94549939 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.58377113 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.58303884 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34182349 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.30717667 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.30010307 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15699427 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14020596 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07379661 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.92625309 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91117365 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.89015419 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85861184 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83279196 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83164479 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79200775 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.77657806 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.74438201 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.67516980 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60707208 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.58108781 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.57224581 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.46076951 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46023882 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.44439594 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44312519 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42419495 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41840753 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36929893 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.35946679 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35131414 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32001867 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26593911 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26278755 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25130879 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21119351 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19754511 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17823406 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.17497981 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15642073 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15336445 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15238834 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14993089 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13146777 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11711713 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.10236253 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.09264479 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06537955 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.05491164 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04926704 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04758859 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03268505 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02544129 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01401299 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.00780590 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99396429 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99311962 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97897146 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95088752 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.95082089 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93947675 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93571931 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91888637 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89747069 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89455491 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.89315308 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85560021 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84917761 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84439931 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82885889 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82641819 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.80424349 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80248502 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78382678 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78233881 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77869390 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77558438 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77219098 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76362578 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75793428 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75405638 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.75289737 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.74949658 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74466451 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74213843 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.72870380 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72453058 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69540834 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69247496 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68140208 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.67055152 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65905279 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65678680 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64988269 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64813126 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.64274487 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63912449 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61909893 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61174391 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59990653 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59218454 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59024854 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58555565 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57761707 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.57589447 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56548511 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.56086653 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.56016113 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54784522 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.54468361 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53668824 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51647071 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51587221 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50797570 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49508783 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49375912 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49098251 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47161055 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43504102 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.42942283 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42662149 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41524343 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.40499438 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40030261 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.39879139 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39687968 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.38932479 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38909143 |

